Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2015, Article ID 510985, 4 pages
http://dx.doi.org/10.1155/2015/510985
Case Report

Early Onset Primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B

1Department of Endocrinology, Waikato Hospital, Private Bag 3200, Hamilton 3240, New Zealand
2Faculty of Medicine and Health Sciences, University of Auckland, Waikato Clinical Campus, Private Bag 3200, Hamilton 3240, New Zealand
3Department of Surgery, Waikato Hospital, Private Bag 3200, Hamilton 3240, New Zealand
4Department of Pathology, Waikato Hospital, Private Bag 3200, Hamilton 3240, New Zealand
5Department of Radiology, Waikato Hospital, Private Bag 3200, Hamilton 3240, New Zealand

Received 7 May 2015; Revised 1 July 2015; Accepted 2 July 2015

Academic Editor: Hidetoshi Ikeda

Copyright © 2015 Marianne S. Elston et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Yu, P. T. Donnan, M. J. Murphy, and G. P. Leese, “Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK,” Clinical Endocrinology, vol. 71, no. 4, pp. 485–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. S. Miller, J. Dimick, R. Wainess, and R. E. Burney, “Age- and sex-related incidence of surgically treated primary hyperparathyroidism,” World Journal of Surgery, vol. 32, no. 5, pp. 795–799, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. L. F. Starker, T. Åkerström, W. D. Long et al., “Frequent germ-line mutations of the MEN1, CASR, and HRPT2/CDC73 genes in young patients with clinically non-familial primary hyperparathyroidism,” Hormones & Cancer, vol. 3, no. 1-2, pp. 44–51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. N. S. Pellegata, L. Quintanilla-Martinez, H. Siggelkow et al., “Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 42, pp. 15558–15563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Tonelli, F. Giudici, F. Giusti et al., “A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome,” European Journal of Endocrinology, vol. 171, no. 2, pp. K7–K17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Georgitsi, A. Raitila, A. Karhu et al., “Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 8, pp. 3321–3325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. K. Agarwal, C. M. Mateo, and S. J. Marx, “Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 5, pp. 1826–1834, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Molatore, I. Marinoni, M. Lee et al., “A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization,” Human Mutation, vol. 31, no. 11, pp. E1825–E1835, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Occhi, D. Regazzo, G. Trivellin et al., “A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotyp,” PLoS Genetics, vol. 9, no. 3, Article ID e1003350, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Polyak, J.-Y. Kato, M. J. Solomon et al., “P27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest,” Genes and Development, vol. 8, no. 1, pp. 9–22, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Costa-Guda, I. Marinoni, S. Molatore, N. S. Pellegata, and A. Arnold, “Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 4, pp. E701–E706, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Malanga, S. De Gisi, M. Riccardi et al., “Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype,” European Journal of Endocrinology, vol. 166, no. 3, pp. 551–560, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Pashtan, R. H. Grogan, S. P. Kaplan et al., “Primary hyperparathyroidism in adolescents: the same but different,” Pediatric Surgery International, vol. 29, no. 3, pp. 275–279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Vierimaa, A. Villablanca, A. Alimov et al., “Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition,” Journal of Endocrinological Investigation, vol. 32, no. 6, pp. 512–518, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Eastell, M. L. Brandi, A. G. Costa, P. D'Amour, D. M. Shoback, and R. V. Thakker, “Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 10, pp. 3570–3579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. A. J. Gill, A. Clarkson, O. Gimm et al., “Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias,” The American Journal of Surgical Pathology, vol. 30, no. 9, pp. 1140–1149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Tomoda, Y. Kubota, and J.-Y. Kato, “Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1,” Nature, vol. 398, no. 6723, pp. 160–165, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. I. A. Adzhubei, S. Schmidt, L. Peshkin et al., “A method and server for predicting damaging missense mutations,” Nature Methods, vol. 7, no. 4, pp. 248–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. G. Knudson Jr., “Mutation and cancer: statistical study of retinoblastoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 4, pp. 820–823, 1971. View at Publisher · View at Google Scholar · View at Scopus
  20. M. L. Fero, E. Randel, K. E. Gurley, J. M. Roberts, and C. J. Kemp, “The murine gene p27Kip1 is haplo-insufficient for tumour suppression,” Nature, vol. 396, no. 6707, pp. 177–180, 1998. View at Publisher · View at Google Scholar · View at Scopus